Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on asymmetric synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113135955B discloses a scalable route for C2 symmetric Trost ligands, offering cost reduction in asymmetric catalysis manufacturing and reliable supply.
Novel nickel-catalyzed asymmetric synthesis of chiral 2-alkyl pyrrolidines. High regioselectivity, room temperature operation, cost-effective for pharma intermediates.
Novel chiral induction route for (R)-3-aminopiperidine eliminates resolution waste. Delivers high ee value and cost reduction in API manufacturing for global supply chains.
Novel synthesis of Sacubitril intermediate via Cu-catalyzed coupling. Reduces cost, improves yield, scalable process for heart failure drug manufacturing.
Patent CN1119321C details a scalable Reformatsky route for ethyl 3S-amino-4-pentynoate, offering high optical purity and cost-effective manufacturing for pharmaceutical intermediates.
Discover the novel chemical resolution method for c-Met inhibitor PF-2341066. This patent analysis highlights cost reduction and scalable manufacturing for pharmaceutical intermediates.
Discover the novel hydroboration-oxidation process for enantiomerically pure 2-(2-arylmorpholin-2-yl)-ethanol derivatives. Enhanced yield and cost efficiency for pharmaceutical manufacturing.
Patent CN107382867B reveals a robust 3-step synthesis for 4-isothiocyanatopyrazolones, enabling cost-effective production of hCE1 inhibitor precursors.
Patent CN116554075A reveals cobalt-catalyzed asymmetric synthesis enabling cost reduction in pharma manufacturing and high-purity intermediate supply chain reliability.
Patent CN104418784B details a novel resolution method for antiviral intermediates. Achieve high de% purity and scalable manufacturing for pharmaceutical supply chains.
Patent CN1639172A details novel silicon-based reagents for high-ee alcohol synthesis, offering scalable routes for complex pharmaceutical intermediates manufacturing.
Discover the novel chiral zinc-nitrogen complex from patent CN102887912A. Enhance asymmetric synthesis capabilities with our reliable supply of specialized catalytic intermediates.
Novel chiral catalytic route for (R)-3-aminopiperidine. Higher yield, lower cost, scalable production for DPP-IV inhibitors. Reliable pharmaceutical intermediates supplier.
Patent CN103420870A details a novel carbonylation route for high-purity chiral 4-cyano-3-hydroxybutyrate, offering significant cost reduction and scalable manufacturing for statin intermediates.
Patent CN1409702A details a cost-effective asymmetric synthesis of Casodex enantiomers using citramalic acid, offering supply chain advantages over proline-based methods.
Patent CN104263774A reveals high-yield yeast catalysis. Offers supply chain reliability and cost reduction in chiral intermediate manufacturing for global pharma.
Discover a novel L-glutamic acid route for multi-chiral tetrahydrofuran rings. High stereoselectivity and mild conditions for cost-effective API manufacturing.
Novel patent CN112830879A details a cost-effective Cinacalcet Hydrochloride synthesis using m-trifluoromethyl benzaldehyde, offering significant supply chain and purity advantages.
Patent CN101973915A details a cost-effective synthesis of carbapenem intermediate 4-BMA using a recoverable chiral sulfonamide auxiliary for improved stereoselectivity.
Advanced Brivaracetam synthesis patent CN106432030A offers high optical purity without heavy metals. Reliable supplier for cost-effective pharmaceutical intermediate manufacturing.